EDGAR Filing Documents for 0001104659-23-125896

Form 8-K - Current report:

SEC Accession No. 0001104659-23-125896

Filing Date

2023-12-14

Accepted

2023-12-14 09:15:30

Documents

Period of Report

2023-12-12

Items

Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2332859d1_8k.htm iXBRL	8-K	43621
2	EXHIBIT 3.1	tm2332859d1_ex3-1.htm	EX-3.1	10544
3	EXHIBIT 99.1	tm2332859d1_ex99-1.htm	EX-99.1	12376
	Complete submission text file	0001104659-23-125896.txt		253226

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA	fwbi-20231212.xsd	EX-101.SCH	3027
5	XBRL TAXONOMY EXTENSION LABEL LINKBASE	fwbi-20231212_lab.xml	EX-101.LAB	34240
6	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	fwbi-20231212_pre.xml	EX-101.PRE	22367
8	EXTRACTED XBRL INSTANCE DOCUMENT	tm2332859d1_8k_htm.xml	XML	3419

Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431

Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020

First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)